⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 25 November, 2025    By - Dr Clemens
A Randomized Controlled Trial Comparing Isobaric Versus Hypobaric Plus Isobaric Bupivacaine in Thoracic Segmental Spinal Anesthesia for the Reduction of Shoulder Pain During Laparoscopic Cholecystectomy

Authors: Chandra R et al. Chandra R, Khan I, Paliwal N W, et al. Source: Cureus. 17(11): e97048. doi:10.7759/cureus.97048. Summary:This randomized controlled trial examined whether using a combination of hypobaric plus isobaric bupivacaine in thoracic segmental spinal anesthesia (TSSA) reduces intraoperative shoulder pain during laparoscopic cholecystectomy compared with isobaric bupivacaine alone. Ninety ASA I–II patients […]

Read More
Uncategorized Published - 25 November, 2025    By - Dr Clemens
Assessing the Impact of a Red Trauma Simulation on Anesthesia Residents’ Confidence, Comfort, and Overnight Call Readiness

Authors: Wasserman R et al. Cureus, 2025; DOI: 10.7759/cureus.93102 SummaryThis study evaluated whether a high-acuity “Red Trauma” simulation could improve new anesthesia residents’ confidence, comfort, and readiness for independent overnight call. Thirteen CA-1 residents participated in a scenario involving a 25-year-old trauma patient with a positive FAST exam, worsening hemodynamics, and initiation of a massive […]

Read More
Uncategorized Published - 25 November, 2025    By - Dr Clemens
A Systematic Review of the Effective Dose of Intrathecal Ropivacaine for Cesarean Section

Authors: Vakiarou F et al. Published in: Cureus, September 2025. DOI: 10.7759/cureus.91480 Summary: This systematic review evaluated all randomized controlled trials that compared different doses of intrathecal ropivacaine for cesarean delivery. Across 10 trials and 756 patients, the authors found substantial heterogeneity in study design, dosing regimens (4 mg to 25 mg), and definitions of […]

Read More
Uncategorized Published - 25 November, 2025    By - Dr Clemens
Remimazolam as a Novel Option for Procedural Sedation

Authors: Ziembicki H et al. Cureus 17(9):e91962, September 10, 2025. DOI: 10.7759/cureus.91962 Remimazolam is an emerging ultra–short-acting benzodiazepine designed to address the major limitations of midazolam in procedural sedation. Unlike midazolam, it does not produce active metabolites and is rapidly hydrolyzed by tissue esterases, creating a predictable onset, quick offset, and faster recovery with far […]

Read More
Uncategorized Published - 25 November, 2025    By - Dr Clemens
Rural hospitals’ labor and delivery closures increased in 2025

Author: Dave Muoio Fierce Healthcare More rural hospitals have closed or are planning to close their labor and delivery units in 2025 than in 2024, bringing the total number of closures since the end of 2020 to 116, according to the Center for Healthcare Quality and Payment Reform (CHQPR). In a November report, the policy […]

Read More